Salim Yazji
2022
In 2022, Salim Yazji earned a total compensation of $962.5K as Chief Medical Officer at GTX, a 52% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $88,140 |
|---|---|
| Option Awards | $188,617 |
| Salary | $448,866 |
| Stock Awards | $224,643 |
| Other | $12,200 |
| Total | $962,466 |
Yazji received $448.9K in salary, accounting for 47% of the total pay in 2022.
Yazji also received $88.1K in non-equity incentive plan, $188.6K in option awards, $224.6K in stock awards and $12.2K in other compensation.
Rankings
In 2022, Salim Yazji's compensation ranked 3,114th out of 5,760 executives tracked by ExecPay. In other words, Yazji earned more than 45.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,114 out of 5,760 | 46th |
Division Manufacturing | 1,748 out of 3,136 | 44th |
Major group Chemicals And Allied Products | 824 out of 1,422 | 42nd |
Industry group Drugs | 769 out of 1,323 | 42nd |
Industry Pharmaceutical Preparations | 559 out of 969 | 42nd |
Source: SEC filing on May 16, 2023.
Yazji's colleagues
We found two more compensation records of executives who worked with Salim Yazji at GTX in 2022.